Penwest Pharmaceuticals Co. said that Endo Pharmaceuticals Inc., its longtime partner for pain drug Opana ER, has agreed to acquire all the common stock of Penwest for $5 per share in cash, in a deal worth approximately $168 million in total equity value. (BioWorld Today)